Immucor Message Board - Msg: 5569007

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thomas Kirwin who wrote (159)	8/23/1998 3:51:00 PM
From: technetx	Read Replies (1) of 422

The only objection I have about this type of analysis is that it is done by "looking in the rear view mirror" . It doesn't tell us anything we don't already know. But thanks for the info. It may help explain some of the heavy selling lately. ******** from report: "This ratio suggests that BLUD is overvalued. Growth to P/E ratio is a popular measure of stock valuation which compares Earnings Growth Rate (GRT) to Price Earnings ratio (P/E). " ********** BLUD's earnings are almost certain to increase from sales of new instruments . Blud's stock price has been declining i.e. future earnings have not been discounted in the present price and , in fact, the opposite has occurred...what's that all about ? Dominic

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next